Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Active not recruiting × mifamurtide × Clear all

Phase

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteosarcoma 1 Neoplasms, Bone Tissue 1

Interventions

pembrolizumab 160 Nivolumab 118 Carboplatin 103 Specimen Handling 97 Cyclophosphamide 94 Paclitaxel 84 Magnetic Resonance Spectroscopy 84 Biopsy 75 Dexamethasone 74 Radiotherapy 72 Cisplatin 72 durvalumab 71 atezolizumab 65 Lenalidomide 56 Ipilimumab 56 Gemcitabine 54 Rituximab 50 Docetaxel 49 olaparib 47 Doxorubicin 46 Bevacizumab 43 Prednisone 40 Oxaliplatin 40 Radiosurgery 38 Fluorouracil 38 Etoposide 38 Radiation 37 Capecitabine 36 venetoclax 33 daratumumab 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03643133 2025-12-26

SARCOME13

UNICANCER

Phase 2 Active not recruiting

Osteosarcoma, Neoplasms, Bone Tissue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡